Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ATRIUM THERAPEUTICS INC
About RNA
Atrium Therapeutics, Inc. is a biopharmaceutical company engaged in the delivery of ribonucleic acid (RNA) therapeutics for people living with cardiomyopathy. Its technology leverages the targeted RNA delivery platform, which combines the tissue selectivity of monoclonal antibodies (mAbs) and other targeted delivery ligands with oligonucleotides. It is designed to allow selective targeting of the underlying genetic drivers of disease. Its development pipeline consists of programs that target genetically validated drivers of cardiomyopathy, which include Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) and Phospholamban (PLN). Its genetic drivers are associated with PRKAG2 syndrome and PLN cardiomyopathy, which is a genetic heart condition associated with life-threatening forms of heart disease. Its programs are supported by preclinical data, in addition to positive clinical data generated in neuromuscular indications using the same RNA delivery platform technology.
Find out what a historical investment in ATRIUM THERAPEUTICS INC would be worth today using our RNA stock calculator.
Market Capitalisation
$201.16M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.12K
High today
$11.89
Low today
$11.45
Open price
$0.00
52-week high
$16.77
52-week low
$11.45
Ready to start your investing journey with Stake?
Open an accountHow do I buy RNA shares in Australia?
Buying RNA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ATRIUM THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RNA
What is the ticker symbol of ATRIUM THERAPEUTICS INC?
The ticker symbol for ATRIUM THERAPEUTICS INC is RNA.
How much is one share of RNA?
One share of RNA is valued at $11.75 as of 10 June 2026.
What is the market capitalisation of ATRIUM THERAPEUTICS INC RNA?
As of 10 June 2026 ATRIUM THERAPEUTICS INC has a market cap of $201.16M.
What is the 52-week high for ATRIUM THERAPEUTICS INC stock?
The ATRIUM THERAPEUTICS INC 52-week high stock price is $16.77.
What is the 52-week low for ATRIUM THERAPEUTICS INC stock?
The ATRIUM THERAPEUTICS INC 52-week low stock price is $11.45.
Can I buy RNA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RNA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RNA on Stake
- Buy RNA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RNA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RNA related stocks